Men who have sex with men (MSM) are at high risk for infections and diseases caused by human papillomavirus (HPV), many of which are vaccine-preventable. In the United States, routine HPV vaccination has been recommended for adolescent males since 2011. This analysis evaluated self-reported receipt of ≥ 1 HPV vaccine dose by age group and HIV status among adult MSM using 2017 data from National HIV Behavioral Surveillance (NHBS) and compared the proportion vaccinated to prior years. Among 10,381 MSM aged ≥ 18 years, 17.9% of MSM overall and 28.4% of MSM living with HIV reported any HPV vaccination. Among 2,482 MSM aged 18–26 years, 32.8% overall and 51.3% living with HIV reported HPV vaccination. Since 2011, the proportion of MSM aged 18–26 years reporting HPV vaccination has increased over six-fold. As vaccinated adolescents age into young adults, coverage will continue to increase overall, including among MSM.

与男性发生性关系（MSM）的男性罹患由人乳头瘤病毒（HPV）引起的感染和疾病的风险很高，其中许多是可以通过疫苗预防的。自2011年以来，在美国，建议对青春期男性进行常规HPV疫苗接种。该分析使用2017年国家艾滋病毒行为监测（NHBS）数据，按年龄组和成年MSM人群中自我报告的≥1 HPV疫苗剂量和HIV状况进行了评估并比较了前几年的疫苗接种比例。在10,381名年龄在18岁以上的MSM中，有17.9％的MSM和28.4％的HIV感染者报告有HPV疫苗接种。在2,482名18-26岁的MSM中，报告有HPV疫苗接种，总体占32.8％，HIV感染者占51.3％。自2011年以来，报告HPV疫苗接种的18-26岁年龄段的MSM比例增加了六倍。随着接种疫苗的青少年逐渐成长为年轻人，